Mediwound Ltd Ord Sh (MDWD) Stock Price, Quote & News

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and ot...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 7 797 14100

Fax: 972 7 797 14111

Website: www.mediwound.com

Address:

42 Hayarkon Street, Yavne, Israel

JohnPDaly Dec. 12 at 4:14 PM

$LCTX $MDWD bought more.

1 · Reply

wblb Dec. 12 at 2:24 PM

$MDWD obviously to 10 lol

0 · Reply

novelty Dec. 12 at 2:24 PM

$MDWD how low we going today fam

0 · Reply

wblb Dec. 12 at 2:23 PM

$MDWD 4092 bad takes and you don't even know the cap structure? Well that explains a lot! kids these days...

0 · Reply

novelty Dec. 11 at 2:21 PM

$MDWD how many shares outstanding on this piggy now

0 · Reply

wblb Dec. 10 at 10:10 PM

$MDWD id say 99% of 5000 stocks don't hold their intra day highs...More STUPIDITY!!!

0 · Reply

novelty Dec. 10 at 9:00 PM

$MDWD can never hold its intra day highs. Thing is just a sellers dream

1 · Reply

novelty Dec. 10 at 8:39 PM

$MDWD should be worth atleast double yet program just can’t stop selling!? Why?

0 · Reply

wblb Dec. 10 at 7:38 PM

$MDWD Sell ur portfolios!!! the market " shredding " has begun. lololo sell sell sell!

0 · Reply

novelty Dec. 10 at 4:32 PM

$MDWD why so much selling if so bullish?

0 · Reply

MediWound Reports New Clinical Data Demonstrating NexoBrid®'s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries

Nov 20, 2025, 10:43 AM EST - 23 days ago

MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript

Nov 20, 2025, 7:00 AM EST - 24 days ago

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 5, 2025, 7:30 AM EST - 5 weeks ago

MediWound to Report Third Quarter 2025 Financial Results

Nov 3, 2025, 8:00 AM EST - 5 weeks ago

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®

Sep 29, 2025, 8:37 AM EDT - 2 months ago

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares

Sep 25, 2025, 7:30 AM EDT - 2 months ago

MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia

Sep 2, 2025, 7:30 AM EDT - 3 months ago

MediWound's NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress

Sep 2, 2025, 5:42 AM EDT - 3 months ago

MediWound Is A Buy Opportunity On The Dip

Aug 20, 2025, 7:30 AM EDT - 4 months ago

MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 14, 2025, 1:31 PM EDT - 4 months ago

MediWound Ltd. (MDWD) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 7:00 AM EDT - 4 months ago

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 13, 2025, 8:45 AM EDT - 4 months ago

MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers

Aug 4, 2025, 7:30 AM EDT - 4 months ago

MediWound to Report Second Quarter 2025 Financial Results

May 21, 2025, 12:46 PM EDT - 7 months ago

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

May 21, 2025, 7:00 AM EDT - 7 months ago

MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 16, 2025, 10:34 AM EDT - 7 months ago

MediWound Ltd.: Undervalued High-Growth Potential

May 13, 2025, 7:30 AM EDT - 7 months ago

MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers

May 5, 2025, 8:00 AM EDT - 7 months ago

MediWound to Report First Quarter 2025 Financial Results

Apr 28, 2025, 8:00 AM EDT - 8 months ago

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

Mar 19, 2025, 12:10 PM EDT - 9 months ago

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 7:00 AM EDT - 9 months ago

MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 3, 2025, 8:00 AM EST - 10 months ago

MediWound to Report Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 8:00 AM EST - 10 months ago

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Feb 24, 2025, 8:00 AM EST - 10 months ago

MediWound to Present at the 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 8:12 AM EST - 10 months ago

MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 7:00 AM EST - 10 months ago

MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

Nov 26, 2024, 1:46 PM EST - 1 year ago

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 7:00 AM EST - 1 year ago

MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update

Oct 29, 2024, 10:49 AM EDT - 1 year ago

MediWound Is A Healthy Investment

Oct 10, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers

Aug 15, 2024, 4:15 PM EDT - 1 year ago

MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 14, 2024, 3:00 PM EDT - 1 year ago

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update

Aug 5, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)

Aug 2, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Second Quarter 2024 Financial Results

Jul 29, 2024, 8:00 AM EDT - 1 year ago

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers

Jul 16, 2024, 7:30 AM EDT - 1 year ago

MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program

Jul 15, 2024, 7:32 AM EDT - 1 year ago

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Jul 15, 2024, 7:00 AM EDT - 1 year ago

MediWound Announces $25 Million Strategic Private Placement Financing

May 29, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

May 29, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports First Quarter 2024 Financial Results and Provides Company Update

May 22, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report First Quarter 2024 Financial Results

Apr 25, 2024, 8:00 AM EDT - 1 year ago

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Mar 21, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 7:00 AM EDT - 1 year ago

MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

Mar 14, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results

Feb 12, 2024, 7:00 AM EST - 1 year ago

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

Feb 5, 2024, 8:00 AM EST - 2 years ago

MediWound to Participate in Two Upcoming Investor Conferences

Jan 9, 2024, 7:00 AM EST - 2 years ago

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

JohnPDaly Dec. 12 at 4:14 PM

$LCTX $MDWD bought more.

1 · Reply

wblb Dec. 12 at 2:24 PM

$MDWD obviously to 10 lol

0 · Reply

novelty Dec. 12 at 2:24 PM

$MDWD how low we going today fam

0 · Reply

wblb Dec. 12 at 2:23 PM

$MDWD 4092 bad takes and you don't even know the cap structure? Well that explains a lot! kids these days...

0 · Reply

novelty Dec. 11 at 2:21 PM

$MDWD how many shares outstanding on this piggy now

0 · Reply

wblb Dec. 10 at 10:10 PM

$MDWD id say 99% of 5000 stocks don't hold their intra day highs...More STUPIDITY!!!

0 · Reply

novelty Dec. 10 at 9:00 PM

$MDWD can never hold its intra day highs. Thing is just a sellers dream

1 · Reply

novelty Dec. 10 at 8:39 PM

$MDWD should be worth atleast double yet program just can’t stop selling!? Why?

0 · Reply

wblb Dec. 10 at 7:38 PM

$MDWD Sell ur portfolios!!! the market " shredding " has begun. lololo sell sell sell!

0 · Reply

novelty Dec. 10 at 4:32 PM

$MDWD why so much selling if so bullish?

0 · Reply

wblb Dec. 10 at 3:14 PM

$MDWD Everyone run for their lives! the flush to 10 is about to happen! lol🤦

0 · Reply

WallStWireAds Dec. 10 at 3:13 PM

$MDWD https://capnotes.beehiiv.com/p/mediwound-is-quietly-expanding-the-value-of-an-fda-approved-drug-and-the-market-may-not-have-noticed

0 · Reply

novelty Dec. 10 at 3:09 PM

$MDWD such bullish news yet all I see are lower highs

0 · Reply

wblb Dec. 10 at 3:00 PM

$MDWD " as markets will get shredded into next few weeks they’ll remove all liquidity from this name and flush it down to 15’s on zero volume cause that’s what they do here. The pump article was for them to re establish short positions."............... let look at the stupidity of this post. Markets get shredded the next few weeks? True babble with no historical relevance on a big up year with santa claus rally coming. Flush down to 15? good call there up 5% on the day on good news. Block this fool!

0 · Reply

wblb Dec. 10 at 12:47 PM

$MDWD Ur constant claims of market crashes and dumb takes with the equity are tiresome, just a few days ago it was can't break 18, then 18.5, last week it was going to 10, now ur number now ur number is 20. 4091 bad takes and now ur blocked.

0 · Reply

JohnPDaly Dec. 10 at 12:11 PM

MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries | MediWound $MDWD https://ir.mediwound.com/news-releases/news-release-details/mediwound-reports-new-clinical-data-demonstrating-nexobridrs

2 · Reply

WallStWireAds Dec. 10 at 12:02 PM

$MDWD https://caplynx.io/BaC1tSW

0 · Reply

novelty Dec. 10 at 2:44 AM

$MDWD 20$, then 18.95, and now 18.8. All lower highs which lead to a smash down downtrend for the ai bots to liquidate longs. Bearish trend until it can break and hold 20 from above

1 · Reply

novelty Dec. 10 at 2:40 AM

$MDWD as markets will get shredded into next few weeks they’ll remove all liquidity from this name and flush it down to 15’s on zero volume cause that’s what they do here. The pump article was for them to re establish short positions.

1 · Reply

novelty Dec. 9 at 11:46 PM

$MDWD nicel lil .40c slap after hours. Bahahaha sub 18 tmrw

0 · Reply

wblb Dec. 9 at 5:29 PM

$MDWD and 4,085 bad prognostications is a sign of insanity and or stupidity.

0 · Reply

novelty Dec. 9 at 5:08 PM

$MDWD paid promo never a good sign

0 · Reply

Market Cap	211.21M
Revenue (ttm)	20.22M
Net Income (ttm)	-30.22M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-149.46%
Debt to Equity Ratio	0.02

Volume	99,500
Avg Vol	74,850
Day's Range	N/A - N/A
Shares Out	11.09M
Stochastic %K	76%
Beta	0.07
Analysts	Strong Sell
Price Target	$31.50